Alabama Clinical Trials

A listing of Alabama clinical trials actively recruiting patient volunteers.

Found in the southeastern United States, people love exploring Alabama for its 1,500 miles of inland waterways. Known as "The Heart of Dixie" and "The Cotton State," the biggest cities include Montgomery, Birmingham, Auburn, and Mobile. Today, Alabama has a diverse economy and one of the most active college athletics scenes in the United States. The University of Alabama Crimson Tide is one of the "winningest" college athletic programs in the country, with football head coach Nick Saban a true local celebrity. UAB Hospitaland the regional Huntsville Hospital are the largest healthcare providers, with the latter serving northern Alabama.

Search by Name
Search
Filter by Condition
1326 trials found

A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)

NCT05358717

The primary goal of this study is to evaluate the safety and pharmacodynamic effects of PTC518 and placebo in participants with HD.

Conditions: Huntington Disease

Minds and Mentors Program- R33

NCT05363371

The proposed research effort will: The purpose of this study is as follows: Test the effectiveness of the Minds and Mentors Program in a group treatment trial in which individuals using medications for opioid use disorder (MOUD) will be randomized in blocks of five to receive either the Minds and Mentors Program (n=120) or Twelve Step Facilitation (n=120). Determine whether the MiMP: a) improves adherence to MOUD b) reduces the rate of relapse and cravings c) decreases self-reported anxiety, s ...

Conditions: Opioid Use Disorder, Substance Use Disorders, Medication Assisted Treatment
Phase: Not Applicable

Early Life Exposures Among Children With Sickle Cell Disease

NCT05377372

This study is being conducted to determine the relationship between early childhood exposures, such as Adverse Childhood Experiences, Social Determinants of Health and nutrition/breastfeeding, among children with sickle cell disease, and behavioral interventions aimed to reshape psychological resilience and lifestyle factors towards positive health outcomes.

Conditions: Sickle Cell Disease, Adverse Childhood Experiences, Breastfeeding
Phase: Not Applicable

Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

NCT05404750

People living with HIV (PLWH) who use drugs experience significant health disparities including lower rates of retention in HIV care and higher rates of unsuppressed viral load, resulting in secondary infections and increased mortality. The proposed study will used mixed methods to explore (a) the relationship between healthcare providers' attitudes towards working with PLWH who use drugs and providers' acceptance and practice of structural and relational harm reduction; (b) the degree to which ...

Conditions: Human Immunodeficiency Virus, Substance Use, Stigma, Social

Effectiveness of CRD-740 in Heart Failure

NCT05409183

This is a two-part study evaluating the effectiveness of CRD-740 in patients with either Heart Failure with Reduced Ejection Fraction (HFrEF) or Heart Failure with Preserved Ejection Fraction (HFpEF) after 12 weeks of treatment. The primary objective in Part A is to assess the effect of CRD-740 compared to placebo in plasma cGMP at Week 4. The primary objective in Part B is to determine whether CRD-740 reduces NT-proBNP compared to placebo at Week 12.

Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Cardiovascular Diseases, Heart Diseases

Oxalate-Driven Host Responses in Kidney Stone Disease

NCT05417568

This study is looking to understand the role of oxalate on kidney stone development and immunity. This study will enroll healthy participants and participants with calcium oxalate kidney stones (CaOx KS). Participants will be in this study for about 3 weeks, consume controlled diets, and provide blood and urine specimens.

Conditions: Kidney Stones
Phase: Not Applicable